Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Hartkopf

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
Anticancer Research|July 5, 2018
Prediction of Non-sentinel Lymph Node Metastases After Positive Sentinel Lymph Nodes Using NomogramsInes Gruber, Maja Henzel, Birgitt Schönfisch, et al.
Geburtshilfe Und Frauenheilkunde|January 16, 2026
Time Toxicity of Endocrine-based Oral CDK4/6 Inhibitor TherapiesHenning Schäffler, Sabine Heublein, Julia Lichtblau, et al.
Journal of Cancer Research and Clinical Oncology|April 29, 2021
Trastuzumab treatment of patients with early, HER2-positive breast cancer in 17 certified German breast cancer centersNora Tabea Sibert, Simone Wesselmann, Clara Breidenbach, et al.
Journal of Medical Internet Research|February 8, 2022
Implementation of an Electronic Patient-Reported Outcome App for Health-Related Quality of Life in Breast Cancer Patients: Evaluation and Acceptability Analysis in a Two-Center Prospective TrialJoachim Graf, Nina Sickenberger, Katharina Brusniak, et al.
Archives of Gynecology and Obstetrics|October 17, 2025
Impact of adjuvant endocrine therapy utilization in male patients with early breast cancer: results from a large German real-world claims data analysisDominik Dannehl, Tjeerd Maarten Hein Dijkstra, Alexandra von Au, et al.
Archives of Gynecology and Obstetrics|September 11, 2015
Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study programAmelie Schramm, Thomas W P Friedl, Fabienne Schochter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2026
Durvalumab in Combination With Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: Long-Term Analysis From the GeparNuevo TrialSibylle Loibl, Michael Untch, Jens Huober, et al.
Geburtshilfe Und Frauenheilkunde|November 11, 2020
Update Breast Cancer 2020 Part 4 - Advanced Breast CancerHans Tesch, Volkmar Müller, Achim Wöckel, et al.
BMC Cancer|February 22, 2018
Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patientsHanna Huebner, Peter A Fasching, Walter Gumbrecht, et al.
International Journal of Molecular Sciences|September 13, 2025
Is Radiographic Aftercare Obsolete? How Testing Positive for ctDNA Can Be a Precedent for Late Relapse, Even in Low-Risk Hormone-Receptor-Positive Breast CancerKerstin Pfister, Sophia Huesmann, Angelina Fink, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Anticancer Research|July 5, 2018
Prediction of Non-sentinel Lymph Node Metastases After Positive Sentinel Lymph Nodes Using NomogramsInes Gruber, Maja Henzel, Birgitt Schönfisch, et al.
Geburtshilfe Und Frauenheilkunde|January 16, 2026
Time Toxicity of Endocrine-based Oral CDK4/6 Inhibitor TherapiesHenning Schäffler, Sabine Heublein, Julia Lichtblau, et al.
Journal of Cancer Research and Clinical Oncology|April 29, 2021
Trastuzumab treatment of patients with early, HER2-positive breast cancer in 17 certified German breast cancer centersNora Tabea Sibert, Simone Wesselmann, Clara Breidenbach, et al.
Journal of Medical Internet Research|February 8, 2022
Implementation of an Electronic Patient-Reported Outcome App for Health-Related Quality of Life in Breast Cancer Patients: Evaluation and Acceptability Analysis in a Two-Center Prospective TrialJoachim Graf, Nina Sickenberger, Katharina Brusniak, et al.
Archives of Gynecology and Obstetrics|October 17, 2025
Impact of adjuvant endocrine therapy utilization in male patients with early breast cancer: results from a large German real-world claims data analysisDominik Dannehl, Tjeerd Maarten Hein Dijkstra, Alexandra von Au, et al.
Archives of Gynecology and Obstetrics|September 11, 2015
Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study programAmelie Schramm, Thomas W P Friedl, Fabienne Schochter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2026
Durvalumab in Combination With Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: Long-Term Analysis From the GeparNuevo TrialSibylle Loibl, Michael Untch, Jens Huober, et al.
Geburtshilfe Und Frauenheilkunde|November 11, 2020
Update Breast Cancer 2020 Part 4 - Advanced Breast CancerHans Tesch, Volkmar Müller, Achim Wöckel, et al.
BMC Cancer|February 22, 2018
Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patientsHanna Huebner, Peter A Fasching, Walter Gumbrecht, et al.
International Journal of Molecular Sciences|September 13, 2025
Is Radiographic Aftercare Obsolete? How Testing Positive for ctDNA Can Be a Precedent for Late Relapse, Even in Low-Risk Hormone-Receptor-Positive Breast CancerKerstin Pfister, Sophia Huesmann, Angelina Fink, et al.
Pageof 9